Nucleosides and Nucleotides. 123. Synthesis of 1-(2-Deoxy-2-isocyano-β-d-arabinofuranosyl)cytosine and Related Nucleosides as Potential Antitumor Agents

Akira Matsuda, Akihito Dan, Noriaki Minakawa, Scott James Tregear, Shinji Okazaki, Yoshikazu Sugimoto, Takuma Sasaki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

2′-Deoxy-2′-isocyanc-1-β-d-arabinofuranosylcytosine (8, NCDAC) has been synthesized as a potential antitumor antimetabolite from a corresponding 2′-azido-2′-deoxy-1-β-d-arabinofuranosyluracil derivative 2a. Uracil and thymine analogues 6a and 6b of 8 were also prepared. Attempts to synthesize 2′-deoxy-2′-isocyanocytidine (14b) failed due to the insertion of the 2′-α isocyano group into the 3′-OH group, affording the 2′,3′-oxazoline derivative 15b. Stability of the isocyano derivative 6a and 2′,3′-oxazoline derivative 15a under basic and acidic conditions were examined. The isocyano group in 6a was stable in basic conditions but unstable even in weakly acidic conditions to furnish the corresponding 2′-β formamide derivative 17. Compound 15a was easily hydrolyzed the corresponding 2′-α formamide derivative 16 on treatment with H2O at room temperature. The cytotoxicity of 8, 6a, and 6b was examined in mouse and human tumor cells in vitro and compared with that of ara-C. Of these nucleosides, 8 was moderately cytotoxic to these cell lines. In vivo antitumor activity of 8 against Lewis lung carcinoma cells was also investigated and 8 showed only moderate tumor volume inhibition.

Original languageEnglish
Pages (from-to)4190-4194
Number of pages5
JournalJournal of Medicinal Chemistry
Volume36
Issue number26
DOIs
Publication statusPublished - 1993 Jan 1

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this